ATE64526T1 - Zubereitung von pregnanolol in einer stabilen oel- in-wasser-emulsion. - Google Patents
Zubereitung von pregnanolol in einer stabilen oel- in-wasser-emulsion.Info
- Publication number
- ATE64526T1 ATE64526T1 AT87850029T AT87850029T ATE64526T1 AT E64526 T1 ATE64526 T1 AT E64526T1 AT 87850029 T AT87850029 T AT 87850029T AT 87850029 T AT87850029 T AT 87850029T AT E64526 T1 ATE64526 T1 AT E64526T1
- Authority
- AT
- Austria
- Prior art keywords
- water emulsion
- pregnanolol
- preparation
- stable oil
- pregnanolone
- Prior art date
Links
- 239000007764 o/w emulsion Substances 0.000 title abstract 2
- AURFZBICLPNKBZ-YZRLXODZSA-N 3alpha-hydroxy-5beta-pregnan-20-one Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)C)[C@@]2(C)CC1 AURFZBICLPNKBZ-YZRLXODZSA-N 0.000 abstract 2
- AURFZBICLPNKBZ-UHFFFAOYSA-N Pregnanolone Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2 AURFZBICLPNKBZ-UHFFFAOYSA-N 0.000 abstract 2
- 229950007402 eltanolone Drugs 0.000 abstract 2
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8600632A SE8600632D0 (sv) | 1986-02-13 | 1986-02-13 | Novel pharmaceutical composition |
| EP87850029A EP0233849B1 (en) | 1986-02-13 | 1987-01-29 | Composition of pregnanolole comprising a stable oil-in-water emulsion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE64526T1 true ATE64526T1 (de) | 1991-07-15 |
Family
ID=20363448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87850029T ATE64526T1 (de) | 1986-02-13 | 1987-01-29 | Zubereitung von pregnanolol in einer stabilen oel- in-wasser-emulsion. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5028600A (enFirst) |
| EP (1) | EP0233849B1 (enFirst) |
| JP (1) | JPH0788305B2 (enFirst) |
| AT (1) | ATE64526T1 (enFirst) |
| CA (1) | CA1301651C (enFirst) |
| DE (1) | DE3770830D1 (enFirst) |
| DK (1) | DK175504B1 (enFirst) |
| ES (1) | ES2037742T3 (enFirst) |
| FI (1) | FI88676C (enFirst) |
| GR (1) | GR3002299T3 (enFirst) |
| HK (1) | HK83293A (enFirst) |
| NO (1) | NO175040B (enFirst) |
| SE (1) | SE8600632D0 (enFirst) |
| SG (1) | SG102892G (enFirst) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9302295D0 (sv) * | 1993-07-02 | 1993-07-02 | Kabi Pharmacia Ab | New pharmaceutical composition |
| US5616330A (en) * | 1994-07-19 | 1997-04-01 | Hemagen/Pfc | Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| US6117429A (en) * | 1997-08-11 | 2000-09-12 | Weider Nutrition International, Inc | Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors |
| WO2000010531A1 (en) | 1998-08-19 | 2000-03-02 | Rtp Pharma Inc. | Injectable aqueous dispersions of propofol |
| WO2002053102A2 (en) * | 2000-12-29 | 2002-07-11 | The Trustees Of Columbia University In The City Of New York | Use of iv emulsions with different triglyceride composition, particle size and apolipoprotein e for targeted tissue delivery of hydrophobic compounds |
| WO2004004739A1 (en) * | 2002-07-02 | 2004-01-15 | Altana Pharma Ag | Ciclesonide-containing sterile aqueous suspension |
| PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
| WO2006030450A2 (en) * | 2004-09-13 | 2006-03-23 | Bharat Serums & Vaccines Ltd. | Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy |
| EP2663326B2 (en) * | 2011-01-14 | 2021-09-29 | Vivacelle Bio, Inc. | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
| WO2013043985A1 (en) * | 2011-09-23 | 2013-03-28 | The Regents Of The University Of California | Edible oils to enhance delivery of orally administered steroids |
| US20150018327A1 (en) | 2012-01-23 | 2015-01-15 | Sage Therapeutics, Inc. | Neuroactive steroid formulations and methods of treating cns disorders |
| US20140050789A1 (en) | 2012-08-13 | 2014-02-20 | The Regents Of The University Of California | Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids |
| CA2882708A1 (en) | 2012-08-21 | 2014-02-27 | Sage Therapeutics, Inc. | Methods of treating epilepsy or status epilepticus |
| DK2925327T3 (da) | 2012-11-30 | 2024-03-25 | Univ California | Allopregnanolon til behandling, reduktion eller lindring af symptomer på fødselsdepression |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| EP3426257A4 (en) | 2016-03-08 | 2019-11-13 | Sage Therapeutics, Inc. | NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF |
| AU2019396217A1 (en) * | 2018-12-10 | 2021-07-08 | Halo Science LLC | Stable formulations of anesthetics and associated dosage forms |
| EP4017498A4 (en) * | 2019-08-19 | 2022-11-09 | Arizona Board of Regents on behalf of the University of Arizona | TOPICAL NEUROSTEROID FORMULATIONS |
| US11969434B1 (en) | 2022-08-29 | 2024-04-30 | Lipocine Inc. | Oral allopregnanolone compositions and methods of use |
| CN114344309B (zh) * | 2021-12-30 | 2024-02-06 | 南京迈诺威医药科技有限公司 | 一种别孕烷醇酮衍生物自乳化制剂及其制备方法 |
| US12186327B2 (en) | 2022-08-29 | 2025-01-07 | Lipocine Inc. | Oral allopregnanolone compositions and methods of use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1215702B (de) * | 1962-07-03 | 1966-05-05 | Merck Ag E | Verfahren zur Herstellung von 1alpha-Alkylthio-3-keto-androstanen |
| CA895860A (en) * | 1969-11-05 | 1972-03-21 | Kruger Gunther | PROCESS FOR THE PREPARATION OF 3.alpha.-HYDROXY-5.beta.-PREGNAN-20-ONE |
| US3900561A (en) * | 1970-12-17 | 1975-08-19 | Glaxo Lab Ltd | Pharmaceutical compositions |
| US3917830A (en) * | 1970-12-17 | 1975-11-04 | Glaxo Lab Ltd | Steroidal anaesthetic composition for intraveneous injection |
| US4168308A (en) * | 1976-03-12 | 1979-09-18 | Apoteksvarucentralen Vitrum Ab | Composition for enhancing the administration of pharmacologically active agents |
| JPS609726B2 (ja) * | 1980-05-15 | 1985-03-12 | 株式会社 ミドリ十字 | ステロイド製剤 |
| JPS5716818A (en) * | 1981-04-25 | 1982-01-28 | Green Cross Corp:The | Steroid fatty emulsion |
| JPS60258110A (ja) * | 1984-06-05 | 1985-12-20 | Daigo Eiyou Kagaku Kk | 静脈注射可能なプロゲステロン乳化注射液 |
-
1986
- 1986-02-13 SE SE8600632A patent/SE8600632D0/xx unknown
-
1987
- 1987-01-29 DE DE8787850029T patent/DE3770830D1/de not_active Expired - Fee Related
- 1987-01-29 ES ES198787850029T patent/ES2037742T3/es not_active Expired - Lifetime
- 1987-01-29 AT AT87850029T patent/ATE64526T1/de not_active IP Right Cessation
- 1987-01-29 EP EP87850029A patent/EP0233849B1/en not_active Expired - Lifetime
- 1987-02-06 DK DK198700621A patent/DK175504B1/da not_active IP Right Cessation
- 1987-02-12 CA CA000529609A patent/CA1301651C/en not_active Expired - Fee Related
- 1987-02-12 JP JP62028395A patent/JPH0788305B2/ja not_active Expired - Fee Related
- 1987-02-12 FI FI870589A patent/FI88676C/fi not_active IP Right Cessation
- 1987-02-12 NO NO870560A patent/NO175040B/no not_active IP Right Cessation
-
1989
- 1989-02-28 US US07/316,576 patent/US5028600A/en not_active Expired - Lifetime
-
1991
- 1991-07-11 GR GR91400996T patent/GR3002299T3/el unknown
-
1992
- 1992-10-07 SG SG1028/92A patent/SG102892G/en unknown
-
1993
- 1993-08-12 HK HK832/93A patent/HK83293A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2037742T3 (es) | 1993-07-01 |
| DE3770830D1 (de) | 1991-07-25 |
| DK62187A (da) | 1987-08-14 |
| SE8600632D0 (sv) | 1986-02-13 |
| NO175040B (no) | 1994-05-16 |
| EP0233849A1 (en) | 1987-08-26 |
| NO870560L (no) | 1987-08-14 |
| EP0233849B1 (en) | 1991-06-19 |
| SG102892G (en) | 1992-12-04 |
| NO870560D0 (no) | 1987-02-12 |
| JPS62192322A (ja) | 1987-08-22 |
| FI870589L (fi) | 1987-08-14 |
| US5028600A (en) | 1991-07-02 |
| NO175040C (enFirst) | 1994-08-24 |
| HK83293A (en) | 1993-08-20 |
| FI870589A0 (fi) | 1987-02-12 |
| FI88676B (fi) | 1993-03-15 |
| DK62187D0 (da) | 1987-02-06 |
| CA1301651C (en) | 1992-05-26 |
| FI88676C (fi) | 1993-06-28 |
| JPH0788305B2 (ja) | 1995-09-27 |
| GR3002299T3 (en) | 1992-12-30 |
| DK175504B1 (da) | 2004-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE64526T1 (de) | Zubereitung von pregnanolol in einer stabilen oel- in-wasser-emulsion. | |
| GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
| ES2075202T3 (es) | Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen. | |
| DE3688114D1 (de) | Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate. | |
| DE3783356D1 (de) | Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| ATE22562T1 (de) | 6-substituierte s-triazolo(3,4-a)phthalazinderivate. | |
| EE03223B1 (et) | Kiiretoimelist dihüdropüridiinühendit sisaldav farmatseutiline emulsioon vererõhu alandamiseks ja selle valmistamise protsess | |
| DZ1468A1 (fr) | Composés nouveaux. | |
| ES8703921A1 (es) | Un procedimiento para preparar emulsiones transparentes de agua en silicona. | |
| IT8720200A0 (it) | Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine. | |
| FI843560A7 (fi) | Mevalonolaktonin analogeja ja niiden johdannaisia, menetelmiä niiden valmistamiseksi, niitä sisältäviä farmaseuttisia yhdistelmiä ja niide n käyttö farmaseuttisina aineina. | |
| ATE27914T1 (de) | Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung. | |
| MA19882A1 (fr) | Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides. | |
| IT8722869A0 (it) | Soluzioni iniettabili pronte all'uso contenenti un glicoside antraciclinico antitumorale. | |
| AU629445B2 (en) | Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol | |
| ES2003658A6 (es) | Procedimiento de preparar derivaods de 2-alquilbenzimidazol. | |
| KR880012226A (ko) | 외 용 제 | |
| ES2016376B3 (es) | Acido n,n-bis-(4-fluorofenil) carbamoilacetohidroxamico y composicion farmaceutica que lo contiene. | |
| KR880000094A (ko) | 위염치료제 | |
| ES8502869A1 (es) | Procedimiento para la estabilizacion de preparados farmaceuticos de prostaglandinas. | |
| KR910011258A (ko) | 녹내장의 치료방법 | |
| KR920000327A (ko) | 비스(3,5-디-알킬-4- 히드록시페닐티오) 메탄을 유효 성분으로 함유하는 고트리글리세리드혈증 치료용 제약 조성물 | |
| KR930012025A (ko) | 한방성 b형 간염치료제 | |
| RO91015B1 (ro) | Solutie injectabila de uz pediatric | |
| SE8704049D0 (sv) | Novel pharmacological compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |